Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Igor Aurer

11286

Igor

Aurer

prof. dr. sc.

Naziv Uloga Akcije
Dijagnostika i liječenje limfoma voditelj
Naziv Akcije
Galunić Bilić, Lea ; Šantek, Fedor ; Grah, Josip Joachim ; Bašić-Kinda, Sandra ; Mandac Smoljanović, Inga ; Ostojić Kolonić, Slobodanka ; Mitrović, Zdravko ; Vodanović, Marijo ; Dujmović, Dino ; Aurer, Igor Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience // Radiologia medica, 128 (2023), 1615, 9. doi: 10.1007/s11547-023-01615-8
Premužić, Vedran ; Bašić-Kinda, Sandra ; Radman, Ivo ; Dujmović, Dino ; Ilić, Ivana ; Živković, Neno ; Maleta, Lucija ; Kralik, Marko ; Dobrenić, Margareta ; Galunić-Bilić, Lea et al. Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma // Medicine, 102 (2023), 20; 33675, 5. doi: 10.1097/MD.0000000000033675
(KroHem) Mitrović, Zdravko ; Dujmović, Dino ; Jakšić, Ozren ; Bašić-Kinda, Sandra ; Gaćina, Petar ; Periša, Vlatka ; Prka, Željko ; Dreta, Barbara ; Galušić Davor ; Holik, Hrvoje et al. Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem) // European journal of haematology, 111 (2023), 13957, 7. doi: 10.1111/ejh.13957
(EORTC Lymphoma Group) Fornecker, Luc-Matthieu ; Lazarovici, Julien ; Aurer, Igor ; Casasnovas, René-Olivier ; Gac, Anne-Claire ; Bonnet, Christophe ; Bouabdallah, Krimo ; Feugier, Pierre ; Specht, Lena ; Molina, Lysiane et al. Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial // Journal of clinical oncology, 41 (2023), 2; 327-335. doi: 10.1200/jco.21.01281
Vibor Milunović, Ida Hude, Goran Rinčić, Davor Galušić, Aron Grubešić, Marko Martinović, Nika Popović, Sunčana Divošević, Klara Brčić, Marin Međugorac, Luka Kužat, Dejan Strahija, Stefan Mrđenović, Inga Mandac Smoljanović, Delfa Radić- Krišto, Slavko Gašparov, Igor Aurer, Slobodanka Ostojić Kolonić Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma // Biomedicines, 10 (2022), 1-22. doi: 10.3390/biomedicines10112917.
Dreyling, Martin ; André, Marc ; Gökbuget, Nicola ; Tilly, Hervé ; Jerkeman, Mats ; Gribben, John ; Ferreri, Andrés ; Morel, Pierre ; Stilgenbauer, Stephan ; Fox, Christopher et al. The EHA Research Roadmap: Malignant Lymphoid Diseases // HemaSphere, 6 (2022), 6; e726, 18. doi: 10.1097/hs9.0000000000000726
Hude Dragičević, Ida ; Bašić-Kinda, Sandra ; Dujmović, Dino ; Radman, Ivo ; Dreta, Barbara ; Dotlić, Sandra ; Galunić- Bilić, Lea ; Dobrenić, Margareta ; Kralik, Marko ; Rončević, Pavle et al. Reduced steroid exposure is safe and does not reduce disease control among Hodgkin lymphoma patients treated with escalated BEACOPP (eBEACOPP) // The 12th International Symposium on Hodgkin Lymphoma Abstract Book, HemaSPhere 6(S5). 2022. str. 8-9
Batinić, Josip ; Vodanović, Marijo ; Rončević, Pavle ; Aurer, Igor Hematologija // Primjeri u kliničkoj medicini / Premužić, Vedran (ur.). Zagreb: Alfa, 2022. str. 55-73
Liker, Milica ; Bašić Kinda, Sandra ; Duraković, Nadira ; Bojanić, Ines ; Aurer, Igor ; Golubić Ćepulić, Branka The appropriateness of platelet transfusions in hematological patients and the potential for improvement // Transfusion clinique et biologique, 31 (2022), 1246-7820, 7. doi: 10.1016/j.tracli.2022.11.007
(EORTC Lymphoma Group) Fiaccadori, Valeria ; Neven, Anouk ; Fortpied, Catherine ; Aurer, Igor ; Andre, Marc ; Federico, Massimo ; Counsell, Nicholas ; Phillips, Elizabeth H. ; Clifton‐Hadley, Laura ; Barrington, Sally F. et al. Relapse patterns in early‐PET negative, limited‐ stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy–a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials // British journal of haematology, 200 (2022), 18594, 9. doi: 10.1111/bjh.18594
nije evidentirano
nije evidentirano